Private biotech 2004--the numbers.
Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.
Hodgson
John
J
Critical I Limited, The Colin Sanders Innovation Centre, Mewburn Road, Banbury, OX16 9PA, UK. john.hodgson@criticali.net
D001709:Biotechnology / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D005060:Europe; D007182:Income / Q000706:statistics & numerical data* / Q000639:trends; D007221:Industry / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D017149:Private Sector / Q000191:economics* / Q000706:statistics & numerical data*; D014481:United States